Stopping and Restarting Mounjaro Weight Loss - UK Guide

Clinically Proven UK Registered Pharmacy

Stopping and Restarting Mounjaro - From £124.99

UK patients access expert restart protocols with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Stopping and Restarting Mounjaro Weight Loss: Clinical Guidance for UK Patients

Published: 10 September 2026

Stopping and restarting Mounjaro weight loss treatment is a common scenario faced by patients due to supply issues, side effects, cost considerations, or treatment holidays. Clinical evidence demonstrates that treatment interruptions can affect weight maintenance outcomes, with many patients experiencing partial weight regain during breaks. Understanding the proper restart protocol, expected outcomes, and strategies to minimise weight fluctuation is essential for long-term success with tirzepatide therapy.

Why Patients Consider Stopping and Restarting Mounjaro Weight Loss Treatment

Stopping and restarting Mounjaro weight loss therapy occurs for multiple reasons in UK clinical practice. Supply chain disruptions throughout 2023 and 2024 forced many patients to pause treatment temporarily, whilst others stop due to gastrointestinal side effects requiring a treatment break before reintroduction at a lower dose [1]. Financial considerations also play a role, with some patients taking planned breaks between weight loss phases.

Treatment interruptions may also be medically necessary before surgical procedures or during acute illness. Clinical data from the SURPASS trials did not specifically examine planned treatment breaks, but post-marketing surveillance indicates that brief interruptions of 2-4 weeks typically allow patients to resume at their previous dose without significant tolerability issues [2]. Longer breaks of 8 weeks or more often require restarting at a lower maintenance dose to minimise gastrointestinal symptoms upon reintroduction.

Weight Regain Patterns When Stopping and Restarting Mounjaro Weight Loss Therapy

Weight regain following cessation of tirzepatide therapy is well-documented in clinical literature. The SURMOUNT-4 withdrawal study demonstrated that patients who discontinued Mounjaro after achieving weight loss regained approximately 14% of their body weight over 52 weeks, compared to continued weight loss in those who maintained treatment [3]. This regain pattern is driven by the return of baseline appetite signalling and metabolic adaptation once GLP-1 and GIP receptor agonism ceases.

The rate and extent of weight regain when stopping and restarting Mounjaro weight loss treatment depends on several factors including duration of treatment break, dietary adherence during the pause, physical activity levels, and individual metabolic characteristics. Patients who maintain structured eating patterns and regular exercise during treatment breaks typically experience slower regain rates. Most weight regain occurs within the first 12 weeks after stopping, with the rate plateauing thereafter [4].

Metabolic Changes During Treatment Breaks

When stopping Mounjaro, the pharmacological suppression of appetite hormones diminishes over 4-5 weeks as tirzepatide clears from the system. Ghrelin levels rise, leptin sensitivity decreases, and gastric emptying returns to baseline rates. These physiological changes explain why hunger and food preoccupation often return within 2-3 weeks of the last injection. Understanding these metabolic shifts helps patients prepare realistic expectations when considering treatment interruptions.

Protocols for Stopping and Restarting Mounjaro Weight Loss Safely

The optimal protocol for stopping and restarting Mounjaro weight loss treatment depends on the duration and reason for the interruption. For planned breaks under 4 weeks, most UK prescribers recommend resuming at the same dose the patient was taking before stopping, as tirzepatide levels remain partially detectable and tolerability is typically maintained [5]. For breaks of 4-8 weeks, clinical judgment is required, with many practitioners restarting one dose level lower to assess tolerability before re-escalating.

For treatment breaks exceeding 8 weeks, the standard recommendation is to restart at the initial 2.5mg dose and follow the original titration schedule. This approach minimises the risk of severe gastrointestinal side effects that can occur when reintroducing higher doses after extended breaks. The titration schedule typically progresses from 2.5mg for 4 weeks, then 5mg for 4 weeks, then 7.5mg for 4 weeks, with further increases to 10mg, 12.5mg, or 15mg based on weight loss response and tolerability.

Managing Side Effects When Restarting Treatment

Patients restarting Mounjaro after extended breaks often experience a recurrence of initial side effects including nausea, reduced appetite, and altered bowel habits. These effects are typically milder than first exposure and resolve within 2-3 weeks at each dose level. Strategies to minimise discomfort include eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection in the evening to allow overnight adaptation. If side effects are intolerable, extending the time at a lower dose before escalating is appropriate.

Treatment Type Frequency Starting Price
Mounjaro GLP-1/GIP injection Weekly from £145.00
Wegovy GLP-1 injection Weekly from £89.00
Wegovy Oral Tablets GLP-1 pill Daily from £83.00
Saxenda GLP-1 injection Daily from £68.00
Foundayo Pill Oral medication Daily from £90.00

Weight Loss Outcomes After Stopping and Restarting Mounjaro Weight Loss Treatment

Clinical experience demonstrates that patients who restart Mounjaro after treatment breaks can achieve similar weight loss outcomes to continuous treatment, though the timeline is extended by the duration of the interruption. Real-world data from UK prescribing practices indicates that patients who regain 5-10% of lost weight during a 3-month break typically re-lose that weight within 8-12 weeks of restarting at therapeutic doses [6].

However, multiple stop-start cycles may reduce overall treatment effectiveness over time. Emerging evidence suggests that repeated interruptions can lead to diminished response with each restart cycle, potentially due to metabolic adaptation or psychological factors affecting adherence. For optimal long-term outcomes, continuous treatment is preferred whenever clinically and financially feasible, with dose adjustments rather than complete cessation used to manage side effects or cost concerns.

Strategies to Minimise Weight Regain When Stopping and Restarting Mounjaro Weight Loss

Patients planning treatment breaks should implement structured behavioural strategies to minimise weight regain during the interruption period. Evidence-based approaches include maintaining a food diary to increase awareness of portion sizes, continuing regular physical activity at 150-300 minutes per week, prioritising protein intake at 1.2-1.6g per kilogram of body weight, and scheduling regular weight monitoring to detect early regain trends [7].

Cognitive behavioural strategies are equally important when stopping and restarting Mounjaro weight loss therapy. Patients should anticipate the return of hunger and food preoccupation, develop non-food coping mechanisms for stress and emotional triggers, and maintain social support structures established during active treatment. Some UK practitioners recommend transitioning to alternative weight management medications during Mounjaro breaks, though this approach requires individual clinical assessment and is not suitable for all patients.

Transitioning to Maintenance Therapy

For patients who have achieved their weight loss goals and wish to reduce treatment intensity, transitioning to a lower maintenance dose rather than stopping completely may preserve more weight loss. Clinical trials are ongoing to establish optimal maintenance protocols, but current practice often involves reducing to the lowest effective dose that maintains weight stability, typically 5mg or 7.5mg for most patients. This approach provides continued appetite regulation whilst reducing cost and injection frequency concerns.

Accessing Stopping and Restarting Mounjaro Weight Loss Support in the UK

UK patients considering stopping and restarting Mounjaro weight loss treatment should discuss their plans with their prescribing clinician to develop an individualised protocol. Cured Pharmacy offers Mounjaro from £124.99 with full clinical assessment by UK-registered prescribers, providing ongoing support for patients managing treatment interruptions. New patients can access £20 off their first order with code Weightlossnew, making restart therapy more affordable.

Our clinical team can advise on appropriate restart dosing based on the duration of your treatment break, previous tolerability, and current weight status. All consultations are conducted by GPhC-registered professionals who understand the complexities of stopping and restarting Mounjaro weight loss therapy. Prescriptions are subject to clinical approval, with same-day prescribing available for suitable patients and discreet delivery across the UK within 1-2 working days [8].

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 10 September 2026]
  2. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 10 September 2026]
  3. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 331(1), 38-48. [accessed 10 September 2026]
  4. Wilding, J. P. H., Batterham, R. L., Davies, M., et al. (2022). Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 24(8), 1553-1564. [accessed 10 September 2026]
  5. Medicines and Healthcare products Regulatory Agency. (2024). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 10 September 2026]
  6. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 29(10), 2473-2483. [accessed 10 September 2026]
  7. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management. NICE guideline [CG189]. [accessed 10 September 2026]
  8. General Pharmaceutical Council. (2024). Standards for registered pharmacies. GPhC. [accessed 10 September 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 10 September 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 10 September 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 10 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long can I stop Mounjaro before needing to restart at the lowest dose?
Treatment breaks under 4 weeks typically allow resuming at your previous dose, whilst breaks exceeding 8 weeks usually require restarting at 2.5mg to minimise side effects when reintroducing tirzepatide therapy.
Will I regain all my weight when stopping and restarting Mounjaro weight loss treatment?
Clinical studies show patients regain an average of 14% of lost weight over one year after stopping, though restarting treatment typically allows re-losing regained weight within 8-12 weeks at therapeutic doses.
Can I take a planned break from Mounjaro every few months to save money?
Whilst financially motivated breaks are common, repeated stop-start cycles may reduce treatment effectiveness over time. Discuss maintenance dosing strategies with your prescriber as a more effective cost-management approach.
What side effects should I expect when restarting Mounjaro after stopping?
Patients restarting after extended breaks often experience mild nausea, reduced appetite, and altered bowel habits similar to initial treatment, though typically less severe and resolving within 2-3 weeks.
How quickly does hunger return after stopping and restarting Mounjaro weight loss therapy?
Most patients notice increased appetite and food preoccupation returning within 2-3 weeks of their last injection as tirzepatide levels decline and baseline hunger hormones re-establish.
Should I follow a special diet during a Mounjaro treatment break?
Maintaining structured eating patterns with high protein intake, regular meal timing, and portion control helps minimise weight regain during breaks. A food diary increases accountability and awareness during interruption periods.
Can I switch to Wegovy instead of restarting Mounjaro after a break?
Switching to alternative GLP-1 medications like Wegovy is possible and may be appropriate depending on individual circumstances, cost considerations, and clinical response. This decision requires prescriber assessment and approval.
How does Cured Pharmacy support patients stopping and restarting Mounjaro weight loss treatment?
Our UK-registered clinical team provides individualised restart protocols based on your break duration and previous response, with Mounjaro available from £124.99 and £20 off first orders using code Weightlossnew.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 10 September 2026

Last updated on 10 September 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 10 September 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (10 September 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.